2025³â 08¿ù 05ÀÏ È­¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92443°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...

¡®ÇÏÆ®Æä¾î¸µ¡¯ Æä¾î¸µºÏ, 33°¡Áö Áú¹®ÀÇ ´äÀÌ Ã¥ÀÌ µÆ´Ù

½Ì±ÛÀÎ ÀÌû¾Æ, Ãֽÿø, ¹Ì¹Ì ´äº¯ÀÌ ±Ã±ÝÇÒ Á¤µµ·Î °¡Ä¡ Àִ å
ä³ÎA »õ ¿¬¾Ö ¿¹´É ‘ÇÏÆ®Æä¾î¸µ’ÀÌ Ã¹ ÃÔ¿µºÎÅÍ ‘°ú¸ôÀÔ’¿¡ ºüÁø 5MC À±Á¾½Å-ÀÌû¾Æ-Ãֽÿø-¹Ì¹Ì-¹ÚÁö¼± ±³¼öÀÇ ½ºÆ©µð¿À ÃÔ¿µ ½ºÆ¿À» °ø°³Çß´Ù. 3¿ù 7ÀÏ(±Ý) ¹ã 10½Ã 50ºÐ ù ¹æ¼ÛÇϴ ä³ÎA ‘ÇÏÆ®Æä¾î¸µ’Àº °áÈ¥ÇÏ°í ½ÍÀº ûÃáµéÀÇ ³¶¸¸°ú ÇöŸ Ãæ¸¸ÇÑ È¥Àü ¿¬¾Ö Àϱ⸦ ±×·Á³»´Â ¿¬¾Ö ÇÁ·Î±×·¥ÀÌ´Ù. ÀÌÁ¦´Â °áÈ¥ÇÒ »ç¶÷°ú ¿¬¾ÖÇÏ°í ½ÍÀº ûÃá³²³àµéÀÌ ´Ü¼øÇÑ ‘½æ’À» ³Ñ¾î, °áÈ¥ »ó´ë¸¦ ã±â À§ÇØ ÁøÁöÇÏ°Ô ¼­·Î¸¦ ¾Ë¾Æ°¡´Â °úÁ¤À» ´ã¾Æ³½´Ù. Ã⿬ÁøµéÀº Áö³­ÇØ ¸» ¾Æ¸§´Ù¿î ³¶¸¸ ...
MBN ¡®ÇÑ ¹øÂë ÀÌÈ¥ÇÒ °á½É¡¯ °üÀü Æ÷ÀÎÆ® (2024-08-18)
Àü±âÂ÷ Á¤ºñ Àü¹®ÀÎÀç ¾ç¼º ÇÁ·Î±×·¥ µµÀÔ (2023-12-25)
Visa Introduces the Visa Tokenized Asset Platform (2024-10-15)
Á¶Ç÷¸ð¼¼Æ÷ ±âÁõ ÀÎ½Ä °³¼± Èñ¸Á¸±·¹ÀÌ Ä·ÆäÀÎ (2017-03-24)
¿ì¸®ÀºÇà, Àεµ Ǫ³×¡¤¾Æ¸Þ´Ù¹Ùµå¿¡ ½Å±Ô ÁöÁ¡ °³¼³ (2024-09-19)
ÀâÄÚ¸®¾Æ, 2¼¼´ë µðÁöÅÐ ¸íÇÔ ¾Û ¡®‡´(nooc)¡¯ Ãâ½Ã (2024-08-24)
LTIMindtree and Microsoft Join Forces to Supercharge AI Inno... (2024-12-09)
µµ½ÃÀÇ ¹Ì·¡ ºñÀü, ¡®µðÁöÅÐ, ½Å·Ú ±¸Ãà, ÀÎÀç À¯Ä¡¡¯°¡ Á¿ì (2023-11-12)
'°³¼Ò¸®' ·ùÇØÁØ, Àαâ À¥Å÷ ÀÛ°¡ º¯½Å ¿¹°í (2024-09-25)
³×½½·¹ÄÚ¸®¾Æ, ÃÊÄݸ´ ºê·£µå ¡®´Ù¸·¡¯ ±¹³» À¯Åë ¹°·® È®´ë (2024-08-04)
BCÄ«µå, ¿ìÁ °áÁ¦»ç¾÷ÀÚ NIPC¿Í ¾ç±¹ °áÁ¦¸Á ¿¬°á (2024-09-02)
[»ê¾÷] »ç¾÷¹æ½Ä Â÷º°È­ÇÑ ½ÅÈï Á¦Á¶ ±â¾÷µé (2016-03-29)
[»ê¾÷] ±Û·Î¹ú ºäƼ »ê¾÷ °æÀï ¾ç»óÀÌ ´Þ¶óÁö°í ÀÖ´Ù (2017-01-15)
Àϵ¿Èĵð½º, ¡®ÇÏÀ̹ÐÅ© »ê¾ç ±ÕÇü¿µ¾ç½Ä¡¯ Ãâ½Ã (2024-06-19)
GS¼¥, ¼ÒÀ¯Áø¼î ·ÐĪ¡¦ Àþ°í °¨°¢ÀûÀÎ ¶óÀÌÇÁ½ºÅ¸ÀÏ Á¦¾È (2024-09-05)
½º¿ìÆÄ 2 Ãâ½Å ¡®·¹À̵ð¹Ù¿î½º¡¯ ù ´Üµ¶ Äܼ­Æ® (2024-06-22)
'°íµù¾öºü' ±è´Üºñ¡¤±è¿µ±Ô ºÎºÎ, »ç»ó ù °èȹ ÀӽŠ(2024-09-11)
±Û·Î¹ú ¼ÒºñÀç »ê¾÷ Á¦Ç° Çõ½Å ºñÀ² »ç»ó ÃÖÀúÄ¡ (2024-08-19)
Çö´ëÂ÷¡¤±â¾Æ, Çѱ¹µµ·Î°ø»ç¿Í °í¼Óµµ·Î ±³Åë¾ÈÀü ¼­ºñ½º °³¹ß (2024-11-28)
Esri Launches Content Store for ArcGIS to Provide Easier Acc... (2025-03-09)
DSI and Frontgrade Sign Agreement to Develop and Distribute ... (2024-12-01)
»ï¼º¹°»ê, īŸ¸£¼­ ¾à 4Á¶¿ø ±Ô¸ð Ç÷£Æ® ¼öÁÖ (2024-12-04)
¹Ù´ÙÀÇ °æ°è¸¦ ³Ñ¾î ¼±À» ³Ñ´Ù¡¦ 2024 ±¹Á¦Çؾ翵ȭÁ¦ °³¸· (2024-07-19)
NTT DATA Announces Intent to Acquire Niveus Solutions to Acc... (2024-12-10)
»ùÇ¥, »þºê»þºê¡¤È̱Ÿ¦ Áý¿¡¼­µµ °£ÆíÇÏ°Ô Áñ±â´Â Á¦Ç° Ãßõ (2024-08-14)
       [ÀÌÀü][1]....[495][496][497][498][499][500][501][502][503]...[3698][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..